Multiresistant uropathogenic Escherichia coli from a region in India where urinary tract infections are endemic: Genotypic and phenotypic characteristics of sequence type 131 isolates of the CTX-M-15 extended-spectrum-β- lactamase-producing lineage

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 12, 2012, Pages 6358-6365

  Hussain, Arif ^a   Ewers, Christa ^b,c   Nandanwar, Nishant ^b   Guenther, Sebastian ^b   Jadhav, Savita ^d   Wieler, Lothar H ^b   Ahmed, Niyaz ^a,e  

^a UNIVERSITY OF HYDERABAD   (India)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c JUSTUS LIEBIG UNIVERSITY   (Germany)

^d HOSPITAL AND RESEARCH CENTRE   (India)

^e UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; CARBAPENEMASE; COTRIMOXAZOLE; TETRACYCLINE;

ARTICLE; BACTERIUM ISOLATION; CONJUGATION; GENETIC VARIABILITY; GENOTYPE; INDIA; INTEGRON; MULTIDRUG RESISTANCE; MULTILOCUS SEQUENCE TYPING; PHENOTYPE; PLASMID; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; REPLICON; SERUM; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI; VIRULENCE;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BACTERIAL TYPING TECHNIQUES; BETA-LACTAMASES; BIOFILMS; CONJUGATION, GENETIC; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ENDEMIC DISEASES; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENOTYPE; INDIA; PHENOTYPE; PLASMIDS; POLYMERASE CHAIN REACTION; URINARY TRACT INFECTIONS; VIRULENCE;

EID: 84869216920     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01099-12     Document Type: Article

References (54)

1. Anderson KF, et al. 2007. Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae. J. Clin. Microbiol. 45:2723-2725.
2. Avasthi TS, et al. 2011. Genome of multidrug-resistant uropathogenic Escherichia coli strain NA114 from India. J. Bacteriol. 193:4272-4273.
3. Bert F, Branger C, Lambert-Zechovsky N. 2002. Identification of PSE and OXA beta-lactamase genes in Pseudomonas aeruginosa using PCRrestriction fragment length polymorphism. J. Antimicrob. Chemother. 50:11-18.
4. Bertrand S, et al. 2006. Clonal emergence of extended-spectrum beta-lactamase (CTX-M-2)-producing Salmonella enterica serovar Virchow isolates with reduced susceptibilities to ciprofloxacin among poultry and humans in Belgium and France (2000 to 2003). J. Clin. Microbiol. 44:2897-2903.
5. Bingen E, et al. 1998. Phylogenetic analysis of Escherichia coli strains causing neonatal meningitis suggests horizontal gene transfer from a predominant pool of highly virulent B2 group strains. J. Infect. Dis. 177:642-650.
6. Blahna MT, et al. 2006. The role of horizontal gene transfer in the spread of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli in Europe and Canada. J. Antimicrob. Chemother. 57:666-672.
7. Boerlin P, et al. 2005. Antimicrobial resistance and virulence genes of Escherichia coli isolates from swine in Ontario. Appl. Environ. Microbiol. 71:6753-6761.
8. Canton R, Coque TM. 2006. The CTX-M beta-lactamase pandemic. Curr. Opin. Microbiol. 9:466-475.
9. Carattoli A, et al. 2005. Identification of plasmids by PCR-based replicon typing. J. Microbiol. Methods 63:219-228.
10. Carrico JA, et al. 2005. Assessment of band-based similarity coefficients for automatic type and subtype classification of microbial isolates analyzed by pulsed-field gel electrophoresis. J. Clin. Microbiol. 43:5483-5490.
11. Chang CY, et al. 2011. Integron types, gene cassettes, antimicrobial resistance genes and plasmids of Shigella sonnei isolates from outbreaks and sporadic cases in Taiwan. J. Med. Microbiol. 60:197-204.
12. Clark G, et al. 2012. Genomic analysis uncovers a phenotypically diverse but genetically homogeneous Escherichia coli ST131 clone circulating in unrelated urinary tract infections. J. Antimicrob. Chemother. 67:868-877.
13. Clermont O, Bonacorsi S, Bingen E. 2000. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl. Environ. Microbiol. 66:4555-4558.
14. Clermont O, et al. 2009. Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains. J. Antimicrob. Chemother. 64:274-277.
15. Clermont O, et al. 2008. The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroup. J. Antimicrob. Chemother. 61:1024-1028.
16. Clinical and Laboratory Standards Institute. 2008. Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals; approved standard - third edition. CLSI document M31-A3. CLSI, Wayne, PA.
17. Clinical and Laboratory Standards Institute. 2009. Performance standards for antimicrobial disk susceptibility tests; approved standard - 10th edition. CLSI document M02-A10. CLSI, Wayne, PA.
18. Dozois CM, Fairbrother JM, Harel J, Bosse M. 1992. pap- and pil-related DNA sequences and other virulence determinants associated with Escherichia coli isolated from septicemic chickens and turkeys. Infect. Immun. 60:2648-2656.
19. Ewers C, Bethe A, Semmler T, Guenther S, Wieler LH. 2012. Extended-spectrum beta-lactamase-producing and AmpC-producing Escherichia coli from livestock and companion animals, and their putative impact on public health: a global perspective. Clin. Microbiol. Infect. 18:646-655.
20. Ewers C, Antao EM, Diehl I, Philipp HC, Wieler LH. 2009. Intestine and environment of the chicken as reservoirs for extraintestinal pathogenic Escherichia coli strains with zoonotic potential. Appl. Environ. Microbiol. 75:184-192.
21. Ewers C, et al. 2010. Emergence of human pandemic O25:H4-ST131 CTX-M-15 extended-spectrum-beta-lactamase-producing Escherichia coli among companion animals. J. Antimicrob. Chemother. 65:651-660.
22. Ewers C, Janssen T, Kiessling S, Philipp HC, Wieler LH. 2004. Molecular epidemiology of avian pathogenic Escherichia coli (APEC) isolated from colisepticemia in poultry. Vet. Microbiol. 104:91-101.
23. Grimm V, et al. 2004. Use of DNA microarrays for rapid genotyping of TEM beta-lactamases that confer resistance. J. Clin. Microbiol. 42:3766-3774.
24. Harding GK, Ronald AR. 1994. The management of urinary infections: what have we learned in the past decade? Int. J. Antimicrob. Agents 4:83-88.
25. Harish BN, Menezes GA, Shekatkar S, Parija SC. 2007. Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae from blood culture. J. Med. Microbiol. 56:999-1000.
26. Hawkey PM. 2008. Prevalence and clonality of extended-spectrum beta-lactamases in Asia. Clin. Microbiol. Infect. 14(Suppl 1):159-165.
27. Heddini A, Cars O, Qiang S, Tomson G. 2009. Antibiotic resistance in China - a major future challenge. Lancet 373:30.
28. Jadhav S, et al. 2011. Virulence characteristics and genetic affinities of multiple drug resistant uropathogenic Escherichia coli from a semi urban locality in India. PLoS One 6:e18063. doi:10.1371/journal.pone.0018063.
29. Jean-Philippe L, et al. 2012. Virulence potential and genomic mapping of the worldwide clone Escherichia coli ST131. PLoS One 7:e34294. doi: 10.1371/journal.pone.0034294.
30. Johnson JR, et al. 2009. Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004. Antimicrob. Agents Chemother. 53:2733-2739.
31. Johnson TJ, Siek KE, Johnson SJ, Nolan LK. 2006. DNA sequence of a ColV plasmid and prevalence of selected plasmid-encoded virulence genes among avian Escherichia coli strains. J. Bacteriol. 188:745-758.
32. Jouini A, et al. 2007. Characterization of CTX-M and SHV extended-spectrum beta-lactamases and associated resistance genes in Escherichia coli strains of food samples in Tunisia. J. Antimicrob. Chemother. 60:1137-1141.
33. Kado CI, Liu ST. 1981. Rapid procedure for detection and isolation of large and small plasmids. J. Bacteriol. 145:1365-1373.
34. Karim A, Poirel L, Nagarajan S, Nordmann P. 2001. Plasmid-mediated extended-spectrum beta-lactamase (CTX-M-3 like) from India and gene association with insertion sequence ISEcp1. FEMS Microbiol. Lett. 201:237-241.
35. Kumarasamy KK, et al. 2010. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect. Dis. 10:597-602.
36. Lau SH, et al. 2008. Major uropathogenic Escherichia coli strain isolated in the northwest of England identified by multilocus sequence typing. J. Clin. Microbiol. 46:1076-1080.
37. CTX-M genes in Escherichia coli strains from Croatian hospitals are located in new (blaCTX-M-3a) and widely spread (blaCTX-M-3a and blaCTX-M-15) genetic structures. Antimicrob. Agents Chemother. 53:1630-1635.
38. Livermore DM, et al. 2007. CTX-M: changing the face of ESBLs in Europe. J. Antimicrob. Chemother. 59:165-174.
39. Maguire AJ, Brown DF, Gray JJ, Desselberger U. 2001. Rapid screening technique for class 1 integrons in Enterobacteriaceae and nonfermenting Gram-negative bacteria and its use in molecular epidemiology. Antimicrob. Agents Chemother. 45:1022-1029.
40. Martinez-Martinez L, Pascual A, Jacoby GA. 1998. Quinolone resistance from a transferable plasmid. Lancet 351:797-799.
41. Naves P, et al. 2008. Measurement of biofilm formation by clinical isolates of Escherichia coli is method-dependent. J. Appl. Microbiol. 105:585-590.
42. Park CH, Robicsek A, Jacoby GA, Sahm D, Hooper DC. 2006. Prevalence in the United States of aac(6′)-Ib-cr encoding a ciprofloxacin-modifying enzyme. Antimicrob. Agents Chemother. 50:3953-3955.
43. Paterson DL, Bonomo RA. 2005. Extended-spectrum beta-lactamases: a clinical update. Clin. Microbiol. Rev. 18:657-686.
44. NDM-1 in an Acinetobacter baumannii strain isolated in Germany in 2007. J. Antimicrob. Chemother. 66:1998-2001.
45. Pitout JD, et al. 2007. Molecular epidemiology of CTX-M-producing Escherichia coli in the Calgary Health Region: emergence of CTX-M-15-producing isolates. Antimicrob. Agents Chemother. 51:1281-1286.
46. Pitout JD, Laupland KB. 2008. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect. Dis. 8:159-166.
47. Rao AN, et al. 2006. Class 1 integrons in resistant Escherichia coli and Klebsiella spp., US hospitals. Emerg. Infect. Dis. 12:1011-1014.
48. Robicsek A, Strahilevitz J, Sahm DF, Jacoby GA, Hooper DC. 2006. qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States. Antimicrob. Agents Chemother. 50:2872-2874.
49. Rodriguez-Siek KE, Giddings CW, Doetkott C, Johnson TJ, Nolan LK. 2005. Characterizing the APEC pathotype. Vet. Res. 36:241-256.
50. Rodriguez I, et al. 2009. Extended-spectrum (1)-lactamases and AmpC (1)-lactamases in ceftiofur-resistant Salmonella enterica isolates from food and livestock obtained in Germany during 2003-07. J. Antimicrob. Chemother. 64:301-309.
51. Rogers BA, Sidjabat HE, Paterson DL. 2011. Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J. Antimicrob. Chemother. 66:1-14.
52. Russo TA, Johnson JR. 2003. Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem. Microbes Infect. 5:449-456.
53. Skurnik D, et al. 2005. Integron-associated antibiotic resistance and phylogenetic grouping of Escherichia coli isolates from healthy subjects free of recent antibiotic exposure. Antimicrob. Agents Chemother. 49:3062-3065.
54. Wirth T, et al. 2006. Sex and virulence in Escherichia coli: an evolutionary perspective. Mol. Microbiol. 60:1136-1151